Center for Personalized Medicine in Oncology

Established in 2023, the Center for Personalized Medicine in Oncology Dresden (ZPMO Dresden) brings together more than 10 years of experience in comprehensive molecular tumor diagnostics and clinical evaluation at the Dresden campus. The center focuses on optimizing and harmonizing personalized medicine workflows, advancing molecular diagnostics, and ensuring high quality standards.

Using state-of-the-art diagnostic and clinical methods, the ZPMO Dresden aims to significantly improve treatment outcomes for patients with advanced cancer. Its work encompasses comprehensive molecular diagnostic testing and personalized treatment recommendations developed by interdisciplinary molecular tumor boards. Thus, the ZPMO Dresden complements the extensive clinical and scientific services of the NCT/UCC Dresden.

• Further information about the center
• Further information about the molecular diagnostics process at the ZPMO